	公開日期	標題	作者	來源出版物	scopus	WOS
1	2023	High-fat diet induces C-reactive protein secretion, promoting lung adenocarcinoma via immune microenvironment modulation	Hsu, Wei-Lun; Hsieh, Yun-Ting; Chen, Wei-Ming; Chien, Min-Hui; Luo, Wei-Jia; Chang, Jung-Hsuan; Devlin, Kevin; KANG-YI SU	Disease models & mechanisms	0	1
2	2023	Whole exome sequencing and MicroRNA profiling of lung adenocarcinoma identified risk prediction features for tumors at stage I and its substages	Ho, Hao; SUNG-LIANG YU ; Chen, Hsuan-Yu; Yuan, Shin-Sheng; KANG-YI SU ; Hsu, Yi-Chiung; Hsu, Chung-Ping; Chuang, Cheng-Yen; Chang, Ya-Hsuan; Li, Yu-Cheng; Cheng, Chiou-Ling; Chang, Gee-Chen; PAN-CHYR YANG ; Li, Ker-Chau	Lung cancer (Amsterdam, Netherlands)	0	0
3	2023	Senomorphic effect of diphenyleneiodonium through AMPK/MFF/DRP1 mediated mitochondrial fission	Liao, Keng-Mao; Chen, Chih-Jung; Luo, Wei-Jia; Hsu, Chen-Wei; SUNG-LIANG YU ; PAN-CHYR YANG ; KANG-YI SU	Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie	1	1
4	2023	MiR-503 pleiotropically regulates epithelial-mesenchymal transition and targets PTK7 to control lung cancer metastasis	TZU-HSIU TSAI ; Gow, Chien-Hung; Liu, Yi-Nan; Tsai, Meng-Feng; Chang, Tzu-Hua; SHANG-GIN WU ; MIN-SHU HSIEH ; KANG-YI SU ; JIN-YUAN SHIH	Cancer medicine	0	0
5	2023	LCRMP-1 is required for spermatogenesis and stabilises spermatid F-actin organization via the PI3K-Akt pathway	Chang, Jung-Hsuan; Chou, Chia-Hua; JUI-CHING WU ; Liao, Keng-Mao; Luo, Wei-Jia; Hsu, Wei-Lun; Chen, Xuan-Ren; SUNG-LIANG YU ; SZU-HUA PAN ; PAN-CHYR YANG ; KANG-YI SU	Communications biology	0	0
6	2022	Tissue Proteogenomic Landscape Reveals the Role of Uncharacterized SEL1L3 in Progression and Immunotherapy Response in Lung Adenocarcinoma	Chi-ya Shen; Chang, Wen-Hsin; Chen, Yi-Ju; Weng, Chia-Wei; Regmi, Prabha; Kier, Mickiela K K; KANG-YI SU ; Chang, Gee-Chen; JIN-SHING CHEN ; Chen, Yu-Ju; SUNG-LIANG YU	Journal of proteome research	4	0
7	2022	Correction to: The Difference in Clinical Outcomes Between Osimertinib and Afatinib for First-Line Treatment in Patients with Advanced and Recurrent EGFR-Mutant Non-Small Cell Lung Cancer in Taiwan	Huang, Yen-Hsiang; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; KANG-YI SU ; SUNG-LIANG YU ; Chen, Jeremy J W; Chang, Gee-Chen	Targeted oncology	0	0
8	2022	Influence of the Timing of Leptomeningeal Metastasis on the Outcome of EGFR-Mutant Lung Adenocarcinoma Patients and Predictors of Detectable EGFR Mutations in Cerebrospinal Fluid	Liao, Pei-Ya; Ou, Wei-Fan; KANG-YI SU ; Sun, Ming-Hsi; Huang, Chih-Mei; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; SUNG-LIANG YU ; Huang, Yen-Hsiang; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chang, Gee-Chen	Cancers	0	0
9	2022	The Difference in Clinical Outcomes Between Osimertinib and Afatinib for First-Line Treatment in Patients with Advanced and Recurrent EGFR-Mutant Non-Small Cell Lung Cancer in Taiwan	Huang, Yen-Hsiang; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; KANG-YI SU ; SUNG-LIANG YU ; Chen, Jeremy J W; Chang, Gee-Chen	Targeted oncology	7	7
10	2022	The Clinical Outcomes of Different First-Line EGFR-TKIs Plus Bevacizumab in Advanced EGFR-Mutant Lung Adenocarcinoma	Huang, Yen-Hsiang; Hsu, Kuo-Hsuan; Chin, Chun-Shih; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; KANG-YI SU ; SUNG-LIANG YU ; Chen, Jeremy J W; Chang, Gee-Chen	Cancer research and treatment	9	6
11	2022	Genetic Deletion of HLJ1 Does Not Affect Blood Coagulation in Mice	Hsu, Man-Chen; Luo, Wei-Jia; Guo, Bei-Chia; Chen, Chia-Hui; Hu, Po-An; Tsai, Yi-Hsuan; KANG-YI SU ; TZONG-SHYUAN LEE	International journal of molecular sciences	0	0
12	2022	Novel Genetic Prognostic Signature for Lung Adenocarcinoma Identified by Differences in Gene Expression Profiles of Low- and High-Grade Histological Subtypes	Chang, Chia-Ching; MIN-SHU HSIEH ; MONG-WEI LIN ; Lee, Yi-Hsuan; Hsiao, Yi-Jing; KANG-YI SU ; Su, Te-Jen; SUNG-LIANG YU ; JIN-SHING CHEN	Biomolecules	3	4
13	2022	Uracil-DNA Glycosylase Assay by Matrix-assisted Laser Desorption/Ionization Time-of-flight Mass Spectrometry Analysis	Chang, Hui-Lan; KANG-YI SU ; Goodman, Steven D; WERN-CHERNG CHENG ; LIANG-IN LIN ; YA-CHIEN YANG ; SUI-YUAN CHANG ; WOEI-HORNG FANG	Journal of visualized experiments : JoVE	1	1
14	2022	Various impacts of driver mutations on the PD-L1 expression of NSCLC	Chu, Cheng-Hsiang; Huang, Yen-Hsiang; Lee, Po-Hsin; Hsu, Kuo-Hsuan; Chen, Kun-Chieh; KANG-YI SU ; SUNG-LIANG YU ; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chang, Gee-Chen	PloS one	3	1
15	2022	PD-L1 strong expressions affect the clinical outcomes of osimertinib in treatment naïve advanced EGFR-mutant non-small cell lung cancer patients	Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; KANG-YI SU ; SUNG-LIANG YU ; Chen, Jeremy J W; Huang, Yen-Hsiang; Chang, Gee-Chen	Scientific reports	11	9
16	2022	HLJ1 amplifies endotoxin-induced sepsis severity by promoting IL-12 heterodimerization in macrophages	Luo, Wei-Jia; SUNG-LIANG YU ; Chang, Chia-Ching; Chien, Min-Hui; Chang, Ya-Ling; Liao, Keng-Mao; Lin, Pei-Chun; KUEI-PIN CHUNG ; YA-HUI CHUANG ; Chen, Jeremy J W; PAN-CHYR YANG ; KANG-YI SU	eLife	7	3
17	2021	Transthyretin as a Biomarker to Predict and Monitor Major Depressive Disorder Identified by Whole-Genome Transcriptomic Analysis in Mouse Models	SUNG-LIANG YU ; Chu, Selina Shih-Ting; Chien, Min-Hui; PO-HSIU KUO ; PAN-CHYR YANG ; KANG-YI SU	Biomedicines	4	4
18	2021	Publisher Correction: The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M	Huang, Yen-Hsiang; Tseng, Jeng-Sen; Hsu, Kuo-Hsuan; Chen, Kun-Chieh; KANG-YI SU ; SUNG-LIANG YU ; Chen, Jeremy J W; Yang, Tsung-Ying; Chang, Gee-Chen	Scientific reports	0	0
19	2021	The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M	Huang, Yen-Hsiang; Tseng, Jeng-Sen; Hsu, Kuo-Hsuan; Chen, Kun-Chieh; KANG-YI SU ; SUNG-LIANG YU ; Chen, Jeremy J W; Yang, Tsung-Ying; Chang, Gee-Chen	Scientific reports	9	9
20	2021	Prognostic Characteristics and Immunotherapy Response of Patients With Nonsquamous NSCLC With Kras Mutation in East Asian Populations: A Single-Center Cohort Study in Taiwan	SHANG-GIN WU ; WEI-YU LIAO ; KANG-YI SU ; SUNG-LIANG YU ; YEN-LIN HUANG ; CHONG-JEN YU ; CHIH-HSIN YANG ; JIN-YUAN SHIH	JTO Clinical and Research Reports	16	0
21	2021	Measurement of uracil-DNA glycosylase activity by matrix assisted laser desorption/ionization time-of-flight mass spectrometry technique	Chang, Hui-Lan; KANG-YI SU ; Goodman, Steven D; Yen, Rong-Syuan; WERN-CHERNG CHENG ; YA-CHIEN YANG ; LIANG-IN LIN ; SUI-YUAN CHANG ; WOEI-HORNG FANG	DNA repair	5	5
22	2021	Primary Tumor Resection Is Associated with a Better Outcome among Advanced EGFR-Mutant Lung Adenocarcinoma Patients Receiving EGFR-TKI Treatment	Tseng, Jeng-Sen; Hsu, Kuo-Hsuan; Zheng, Zhe-Rong; Yang, Tsung-Ying; Chen, Kun-Chieh; Huang, Yen-Hsiang; KANG-YI SU ; SUNG-LIANG YU ; Chang, Gee-Chen	Oncology	9	9
23	2020	Copy Number Alterations of Depressed Colorectal Neoplasm Predict the Survival and Response to Oxaliplatin in Proximal Colon Cancer	LI-CHUN CHANG ; HAN-MO CHIU ; Ho, Bing-Ching; Chen, Min-Hsuan; Hsu, Yin-Chen; Chiu, Wei-Tzu; KANG-YI SU ; CHIA-TUNG SHUN ; JIN-TUNG LIANG ; SUNG-LIANG YU ; MING-SHIANG WU	Cancers	5	5
24	2020	Proofreading of single nucleotide insertion/deletion replication errors analyzed by MALDI-TOF mass spectrometry assay	Chang, Hui Lan; KANG-YI SU ; Goodman, Steven D.; Chou, Neng An; Lin, Kuei Ching; WERN-CHERNG CHENG ; LIANG-IN LIN ; SUI-YUAN CHANG ; WOEI-HORNG FANG	DNA Repair	1	1
25	2020	Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors	CHING-YAO YANG ; WEI-YU LIAO ; CHAO-CHI HO ; KUAN-YU CHEN ; TZU-HSIU TSAI ; CHIA-LIN HSU ; KANG-YI SU ; YIH-LEONG CHANG ; CHEN-TU WU ; Chia-Chi Hsu; BIN-CHI LIAO ; Wei-Hsun Hsu; JIH-HSIANG LEE ; CHIA-CHI LIN ; JIN-YUAN SHIH ; CHIH-HSIN YANG ; CHONG-JEN YU	European Journal of Cancer	55	49
26	2020	Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib	CHING-YAO YANG ; WEI-YU LIAO ; CHAO-CHI HO ; KUAN-YU CHEN ; TZU-HSIU TSAI ; CHIA-LIN HSU ; Liu, Yi-Nan; KANG-YI SU ; YIH-LEONG CHANG ; CHEN-TU WU ; BIN-CHI LIAO ; Hsu, Chia-Chi; Hsu, Wei-Hsun; JIH-HSIANG LEE ; CHIA-CHI LIN ; JIN-YUAN SHIH ; CHIH-HSIN YANG ; CHONG-JEN YU	Oncologist	15	15
27	2020	Proteogenomics of Non-smoking Lung Cancer in East Asia Delineates Molecular Signatures of Pathogenesis and Progression	Chen, Yi-Ju; Roumeliotis, Theodoros I; Chang, Ya-Hsuan; Chen, Ching-Tai; Han, Chia-Li; MIAO-HSIA LIN ; HUEI-WEN CHEN ; Chang, Gee-Chen; YIH-LEONG CHANG ; CHEN-TU WU ; MONG-WEI LIN ; MIN-SHU HSIEH ; Wang, Yu-Tai; Chen, Yet-Ran; Jonassen, Inge; Ghavidel, Fatemeh Zamanzad; Lin, Ze-Shiang; Lin, Kuen-Tyng; Chen, Ching-Wen; Sheu, Pei-Yuan; Hung, Chen-Ting; Huang, Ke-Chieh; Yang, Hao-Chin; Lin, Pei-Yi; Yen, Ta-Chi; Lin, Yi-Wei; Wang, Jen-Hung; Raghav, Lovely; Lin, Chien-Yu; Chen, Yan-Si; Wu, Pei-Shan; Lai, Chi-Ting; Weng, Shao-Hsing; KANG-YI SU ; Chang, Wei-Hung; Tsai, Pang-Yan; Robles, Ana I; Rodriguez, Henry; Hsiao, Yi-Jing; Chang, Wen-Hsin; Sung, Ting-Yi; JIN-SHING CHEN ; SUNG-LIANG YU ; Choudhary, Jyoti S; Chen, Hsuan-Yu; PAN-CHYR YANG ; Chen, Yu-Ju	Cell	154	134
28	2020	ALK variants, PD-L1 expression, and their association with outcomes in ALK-positive NSCLC patients	Chang, Gee-Chen; Yang, Tsung-Ying; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Huang, Yen-Hsiang; KANG-YI SU ; SUNG-LIANG YU ; Tseng, Jeng-Sen	Scientific reports	26	20
29	2019	Improved Dried Blood Spot-Based Metabolomics Analysis by a Postcolumn Infused-Internal Standard Assisted Liquid Chromatography-Electrospray Ionization Mass Spectrometry Method	Chepyala, Divyabharathi; Kuo, Han Chun; KANG-YI SU ; Liao, Hsiao Wei; Wang, San Yuan; Chepyala, Surendhar Reddy; LIN-CHAU CHANG ; CHING-HUA KUO	Analytical Chemistry	14	10
30	2019	High PD-L1 expression correlates with primary resistance to EGFR-TKIs in treatment naïve advanced EGFR-mutant lung adenocarcinoma patients	Hsu K.-H.; Huang Y.-H.; Tseng J.-S.; Chen K.-C.; Ku W.-H.; KANG-YI SU ; Chen J.J.W.; HUEI-WEN CHEN ; SUNG-LIANG YU ; Yang T.-Y.; Chang G.-C.	Lung Cancer	64	52
31	2019	Metabolomics Investigation of Voriconazole-Induced Hepatotoxicity in Mice	Wu S.-L.; Wei T.-Y.; SHU-WEN LIN ; KANG-YI SU ; CHING-HUA KUO	Chemical Research in Toxicology	13	13
32	2019	Perinatal polychlorinated biphenyls and polychlorinated dibenzofurans exposure are associated with DNA methylation changes lasting to early adulthood: Findings from Yucheng second generation	KANG-YI SU ; Li M.-C.; Lee N.-W.; Ho B.-C.; Cheng C.-L.; Chuang Y.-C.; SUNG-LIANG YU ; Yue Leon Guo	Environmental Research	17	15
33	2018	Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan	SHU-YUNG LIN ; Yang C.-Y.; BIN-CHI LIAO ; CHAO-CHI HO ; WEI-YU LIAO ; KUAN-YU CHEN ; TZU-HSIU TSAI ; CHIA-LIN HSU ; Hsu W.-H.; KANG-YI SU ; YIH-LEONG CHANG ; JIH-HSIANG LEE ; CHIA-CHI LIN ; JIN-YUAN SHIH ; CHIH-HSIN YANG ; CHONG-JEN YU	Journal of Cancer	40	41
34	2018	Novel therapeutic drug identification and gene correlation for fatty liver disease using high-content screening: Proof of concept	Luo W.-J.; Cheng T.-Y.; Wong K.-I.; WOEI-HORNG FANG ; Liao K.-M.; Hsieh Y.-T.; KANG-YI SU	European Journal of Pharmaceutical Sciences	9	9
35	2018	Characteristics and Predictive Value of PD-L1 Status in Real-World NonSmall Cell Lung Cancer Patients	Tseng J.-S.; Yang T.-Y.; Wu C.-Y.; Ku W.-H.; Chen K.-C.; Hsu K.-H.; Huang Y.-H.; KANG-YI SU ; SUNG-LIANG YU ; Chang G.-C.	Journal of Immunotherapy	29	25
36	2018	Proofreading and DNA repair assay using single nucleotide extension and MALDI-TOF mass spectrometry analysis	KANG-YI SU ; Goodman S.D.; Lai H.-M.; Yen R.-S.; Hu W.-Y.; WERN-CHERNG CHENG ; LIANG-IN LIN ; YA-CHIEN YANG ; WOEI-HORNG FANG	Journal of Visualized Experiments	4	4
37	2018	Intercalated treatment following rebiopsy is associated with a shorter progression-free survival of osimertinib treatment	Tseng J.-S.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Huang Y.-H.; KANG-YI SU ; SUNG-LIANG YU ; Chang G.-C.	Cancer Research and Treatment	5	5
38	2018	Clinicopathological and genomic comparisons between different histologic components in combined small cell lung cancer and non-small cell lung cancer	MONG-WEI LIN ; KANG-YI SU ; Su T.-J.; Chang C.-C.; Lin J.-W.; Lee Y.-H.; SUNG-LIANG YU ; JIN-SHING CHEN ; MIN-SHU HSIEH	Lung Cancer	42	33
39	2018	Mutational monitoring of EGFR T790M in cfDNA for clinical outcome prediction in EGFR-mutant lung adenocarcinoma	KANG-YI SU ; Tseng J.-S.; Liao K.-M.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; PAN-CHYR YANG ; SUNG-LIANG YU ; Chang G.-C.	PLoS ONE	17	13
40	2018	Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study	CHIA-CHI LIN ; JIN-YUAN SHIH ; CHONG-JEN YU ; CHAO-CHI HO ; WEI-YU LIAO ; JIH-HSIANG LEE ; TZU-HSIU TSAI ; KANG-YI SU ; MIN-SHU HSIEH ; YIH-LEONG CHANG ; Bai Y.-Y.; DE-RUI HUANG ; Thress K.S.; CHIH-HSIN YANG	The Lancet Respiratory Medicine	120	109
41	2018	DNA polymerase I proofreading exonuclease activity is required for endonuclease V repair pathway both in vitro and in vivo	KANG-YI SU ; LIANG-IN LIN ; Goodman S.D.; Yen R.-S.; Wu C.-Y.; Chang W.-C.; YA-CHIEN YANG ; WERN-CHERNG CHENG ; WOEI-HORNG FANG	DNA Repair	8	8
42	2018	The association of acquired T790M mutation with clinical characteristics after resistance to first-line epidermal growth factor receptor tyrosine kinase inhibitor in lung adenocarcinoma	Huang, Yen-Hsiang; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Chen, Kun-Chieh; Hsu, Chia-Hung; KANG-YI SU ; Chen, Jeremy J W; HUEI-WEN CHEN ; SUNG-LIANG YU ; Yang, Tsung-Ying; Chang, Gee-Chen	Cancer Research and Treatment	47	45
43	2018	Application of single nucleotide extension and MALDI-TOF mass spectrometry in proofreading and DNA repair assay	KANG-YI SU ; Lai H.-M.; Goodman S.D.; Hu W.-Y.; WERN-CHERNG CHENG ; LIANG-IN LIN ; YA-CHIEN YANG ; WOEI-HORNG FANG	DNA Repair	5	4
44	2018	FAM198B is associated with prolonged survival and inhibits metastasis in lung adenocarcinoma via blockage of ERK-Mediated MMP-1 expression	Hsu C.-Y.; Chang G.-C.; Chen Y.-J.; Hsu Y.-C.; Hsiao Y.-J.; KANG-YI SU ; Chen H.-Y.; Lin C.-Y.; JIN-SHING CHEN ; Chen Y.-J.; Hong Q.-S.; Ku W.-H.; Wu C.-Y.; Ho B.-C.; Chiang C.-C.; PAN-CHYR YANG ; SUNG-LIANG YU	Clinical Cancer Research	20	20
45	2017	Rapid Sputum Multiplex Detection of the M. tuberculosis Complex (MTBC) and Resistance Mutations for Eight Antibiotics by Nucleotide MALDI-TOF MS	KANG-YI SU ; BO-SHIUN YAN ; HAO-CHIEH CHIU ; CHONG-JEN YU ; Chang S.-Y.; Jou R.; Liu J.-L.; PO-REN HSUEH ; SUNG-LIANG YU	Scientific Reports	16	10
46	2017	Gene expression of MAGE-A3 and PRAME tumor antigens and EGFR mutational status in Taiwanese non–small cell lung cancer patients	SZU-HUA PAN ; KANG-YI SU ; Spiessens B.; Kusuma N.; Delahaye N.F.; Gruselle O.; Myo A.; de Creus A.; Louahed J.; Chang G.-C.; SUNG-LIANG YU ; PAN-CHYR YANG	Asia-Pacific Journal of Clinical Oncology	13	14
47	2017	EGFR mutation, smoking, and gender in advanced lung adenocarcinoma	Tseng, Chien-Hua; CHUN-JU CHIANG ; Tseng, Jeng-Sen; Yang, Tsung-Ying; Hsu, Kuo-Hsuan; Chen, Kun-Chieh; Wang, Chih-Liang; Chen, Chih-Yi; Yen, Sang-Hue; Tsai, Chun-Ming; Huang, Ming-Shyan; CHAO-CHI HO ; CHONG-JEN YU ; Tsai, Ying-Huang; JIN-SHING CHEN ; Chou, Teh-Ying; Tsai, Ming-Hsun; Chen, Hsuan-Yu; KANG-YI SU ; Chen, Jeremy J. W.; HUEI-WEN CHEN ; SUNG-LIANG YU ; Liu, Tsang-Wu; MONG-HSUN TSAI	Oncotarget	54	41
48	2016	Higher frequency but random distribution of EGFR mutation subtypes in familial lung cancer patients	Hsu K.-H.; Tseng J.-S.; Wang C.-L.; Yang T.-Y.; Tseng C.-H.; Chen H.-Y.; Chen K.-C.; Tsai C.-R.; Yang C.-T.; SUNG-LIANG YU ; KANG-YI SU ; CHONG-JEN YU ; CHAO-CHI HO ; Hsia T.-C.; Wu M.-F.; Chiu K.-L.; Liu C.-M.; PAN-CHYR YANG ; Chen J.J.W.; Chang G.-C.	Oncotarget	9	9
49	2016	SPANXA suppresses EMT by inhibiting c-JUN/SNAI2 signaling in lung adenocarcinoma	Hsiao Y.-J.; KANG-YI SU ; Hsu Y.-C.; Chang G.-C.; JIN-SHING CHEN ; Chen H.-Y.; Hong Q.-S.; Hsu S.-C.; Kang P.-H.; Hsu C.-Y.; Ho B.-C.; Yang T.-H.; Wang C.-Y.; Jou Y.-S.; PAN-CHYR YANG ; SUNG-LIANG YU	Oncotarget	23	23
50	2016	Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis	Chen L.-Y.; Molina-Vila M.A ; SHENG-YUAN RUAN ; KANG-YI SU ; WEI-YU LIAO ; KAI-LUN YU ; CHAO-CHI HO ; JIN-YUAN SHIH ; CHONG-JEN YU ; CHIH-HSIN YANG ; Rosell R.; PAN-CHYR YANG	Lung Cancer	57	52
51	2016	Implementation and Quality Control of Lung Cancer EGFR Genetic Testing by MALDI-TOF Mass Spectrometry in Taiwan Clinical Practice	KANG-YI SU ; JAU-TSUEN KAO ; Ho B.-C.; Chen H.-Y.; Chang G.-C.; CHAO-CHI HO ; SUNG-LIANG YU	Scientific Reports	11	11
52	2016	JAG1 is associated with poor survival through inducing metastasis in lung cancer	Chang W.-H.; Ho B.-C.; Hsiao Y.-J.; JIN-SHING CHEN ; Yeh C.-H.; Chen H.-Y.; Chang G.-C.; KANG-YI SU ; SUNG-LIANG YU	PLoS ONE	30	29
53	2016	The emergence of T790M mutation in EGFR-mutant lung adenocarcinoma patients having a history of acquired resistance to EGFR-TKI: Focus on rebiopsy timing and long-term existence of T790M	Tseng J.-S.; KANG-YI SU ; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Chen H.-Y.; Tsai C.-R.; SUNG-LIANG YU ; Chang G.-C.	Oncotarget	24	23
54	2016	Dichloromethane extracts of propolis protect cell from oxygenglucose deprivation-induced oxidative stress via reducing apoptosis	Sun L.-P.; Xu X.; Hwang H.-H.; Wang X.; KANG-YI SU ; Chen Y.-L.S.	Food and Nutrition Research	12	10
55	2016	Predilection of contralateral upper lung metastasis in upper lobe lung adenocarcinoma patients	Huang Y.-H.; Hsu K.-H.; Tseng J.-S.; Chen K.-C.; KANG-YI SU ; Chen H.-Y.; Chang C.-S.; Chen J.J.W.; SUNG-LIANG YU ; HUEI-WEN CHEN ; Yang T.-Y.; Chang G.-C.	Journal of Thoracic Disease	2	2
56	2016	HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual mechanisms	Chen C.-H.; Chang W.-H.; KANG-YI SU ; Ku W.-H.; Chang G.-C.; Hong Q.-S.; Hsiao Y.-J.; Chen H.-C.; Chen H.-Y.; Wu R.; PAN-CHYR YANG ; Chen J.J.W.; SUNG-LIANG YU	Oncogene	21	21
57	2016	Small molecule T315 promotes casitas b-lineage lymphoma dependent degradation of epidermal growth factor receptor via Y1045 autophosphorylation	Huang K.-Y.; Kao S.-H.; Wang W.-L.; Chen C.-Y.; Hsiao T.-H.; Salunke S.B.; Chen J.J.W.; KANG-YI SU ; Yang S.-C.; Hong T.-M.; Chen C.-S.; PAN-CHYR YANG	American Journal of Respiratory and Critical Care Medicine	18	18
58	2016	Molecular gene signature and prognosis of non-small cell lung cancer	Huang P.; Cheng C.-L.; Chang Y.-H.; Liu C.-H.; Hsu Y.-C.; JIN-SHING CHEN ; Chang G.-C.; Ho B.-C.; KANG-YI SU ; Chen H.-Y.; SUNG-LIANG YU	Oncotarget	17	16
59	2015	HOXA5 inhibits metastasis via regulating cytoskeletal remodelling and associates with prolonged survival in non-small-cell lung carcinoma	Wang C.-C.; KANG-YI SU ; Chen H.-Y.; Chang S.-Y.; Shen C.-F.; Hsieh C.-H.; Hong Q.-S.; Chiang C.-C.; Chang G.-C.; SUNG-LIANG YU ; Chen J.J.W.	PLoS ONE	38	32
60	2015	Identification of Five Driver Gene Mutations in Patients with Treatment-Naïve Lung Adenocarcinoma in Taiwan	Hsu K.-H.; CHAO-CHI HO ; Hsia T.-C.; Tseng J.-S.; KANG-YI SU ; Wu M.-F.; Chiu K.-L.; Yang T.-Y.; Chen K.-C.; Ooi H.; Wu T.-C.; Chen H.-J.; Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; KUAN-YU CHEN ; WEI-YU LIAO ; JIN-YUAN SHIH ; SUNG-LIANG YU ; CHONG-JEN YU ; PAN-CHYR YANG ; Chang G.-C.	PLoS ONE	98	92
61	2015	Dynamic plasma EGFR mutation status as a predictor of EGFR-TKI efficacy in patients with EGFR-mutant lung adenocarcinoma	Tseng, Jeng-Sen; Yang, Tsung-Ying; Tsai, Chi-Ren; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Tsai, Meen-Hsin; SUNG-LIANG YU ; KANG-YI SU ; Chen, Jeremy J. W.; MONG-HSUN TSAI	Journal of Thoracic Oncology	63	61
62	2015	EGFR mutation and lobar location of lung adenocarcinoma	Tseng C.-H.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; CHAO-CHI HO ; Hsia T.-C.; KANG-YI SU ; Wu M.-F.; Chiu K.-L.; Liu C.-M.; Wu T.-C.; Chen H.-J.; Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; KUAN-YU CHEN ; WEI-YU LIAO ; JIN-YUAN SHIH ; SUNG-LIANG YU ; CHONG-JEN YU ; PAN-CHYR YANG ; Yang T.-Y.; Chang G.-C.	Carcinogenesis	13	12
63	2015	R331W missense mutation of oncogene YAP1 is a germline risk allele for lung adenocarcinoma with medical actionability	Chen H.-Y.; SUNG-LIANG YU ; Ho B.-C.; KANG-YI SU ; Hsu Y.-C.; Chang C.-S.; Li Y.-C.; Yang S.-Y.; Hsu P.-Y.; Ho H.; Chang Y.-H.; Chen C.-Y.; Yang H.-I.; Hsu C.-P.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; Hsia J.-Y.; Chuang C.-Y.; Yuan S.; Lee M.-H.; Liu C.-H.; Wu G.-I.; Hsiung C.A.; Chen Y.-M.; Wang C.-L.; Huang M.-S.; CHONG-JEN YU ; KUAN-YU CHEN ; Tsai Y.-H.; Su W.-C.; HUEI-WEN CHEN ; Chen J.J.W.; Chen C.-J.; Chang G.-C.; PAN-CHYR YANG ; Li K.-C.	Journal of Clinical Oncology	76	71
64	2014	3,4-Dihydroxytoluene, a metabolite of rutin, inhibits inflammatory responses in lipopolysaccharide-activated macrophages by reducing the activation of NF-κB signaling	KANG-YI SU ; Yu C.Y.; Chen Y.-P.; Hua K.-F.; Chen Y.-L.S.	BMC Complementary and Alternative Medicine	47	45
65	2014	Shisa3 is associated with prolonged survival through promoting β-catenin degradation in lung cancer	Chen C.-C.; Chen H.-Y.; KANG-YI SU ; Hong Q.-S.; BO-SHIUN YAN ; Chen C.-H.; SZU-HUA PAN ; YIH-LEONG CHANG ; Wang C.-J.; Hung P.-F.; Yuan S.; Chang G.-C.; Chen J.J.W.; PAN-CHYR YANG ; YA-CHIEN YANG ; SUNG-LIANG YU	American Journal of Respiratory and Critical Care Medicine	30	33
66	2014	Impact of EGFR mutation detection methods on the efficacy of erlotinib in patients with advanced EGFR-wild type lung adenocarcinoma	Tseng, Jeng-Sen; Wang, Chih-Liang; Huang, Ming-Shyan; CHUNG-YU CHEN ; Chang, Cheng-Yu; Yang, Tsung-Ying; Tsai, Chi-Ren; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Tsai, Meen-Hsin; SUNG-LIANG YU ; KANG-YI SU ; Wu, Chih-Wei; Yang, Cheng-Ta; Chen, Yuh-Min; MONG-HSUN TSAI	PLoS ONE	12	12
67	2014	Taiwanese green propolis and propolin G protect the liver from the pathogenesis of fibrosis via eliminating TGF-β-induced Smad2/3 phosphorylation	KANG-YI SU ; Hsieh C.-Y.; Chen Y.-W.; Chuang C.-T.; Chen C.-T.; Chen Y.-L.S.	Journal of Agricultural and Food Chemistry	29	27
68	2014	Prior EGFR tyrosine-kinase inhibitor therapy did not influence the efficacy of subsequent pemetrexed plus platinum in advanced chemonaïve patients with EGFR-mutant lung adenocarcinoma	Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; CHONG-JEN YU ; WEI-YU LIAO ; Tsai, Chi-Ren; Tsai, Meen-Hsin; SUNG-LIANG YU ; KANG-YI SU ; Chen, Jeremy Jw; Chen, Hsuan-Yu; MONG-HSUN TSAI	OncoTargets and Therapy	15	14
69	2014	Rutin, a flavonoid and principal component of Saussurea involucrata, attenuates physical fatigue in a forced swimming mouse model	KANG-YI SU ; Yu C.Y.; Chen Y.-W.; Huang Y.-T.; Chen C.-T.; Wu H.-F.; Sophia Chen Y.-L.	International Journal of Medical Sciences	71	68
70	2013	Potential therapeutic role of hispidulin in gastric cancer through induction of apoptosis via NAG-1 signaling	Yu C.Y.; KANG-YI SU ; Lee P.-L.; Jhan J.-Y.; Tsao P.-H.; Chan D.-C.; Chen Y.-L.S.	Evidence-based Complementary and Alternative Medicine	35	31
71	2012	R26R-GR: A Cre-Activable Dual Fluorescent Protein Reporter Mouse	YOU-TZUNG CHEN ; Tsai M.-S.; TSUNG-LIN YANG ; Ku A.T.; Huang K.-H.; Huang C.-Y.; Chou F.-J.; Fan H.-H.; JIN-BON HONG ; Yen S.-T.; Wang W.-L.; Lin C.-C.; Hsu Y.-C.; KANG-YI SU ; Su I.-C.; Jang C.-W.; Behringer R.R.; Favaro R.; Nicolis S.K.; CHUNG-LIANG CHIEN ; SHU-WHA LIN ; Yu I.-S.	PLoS ONE	13	10
72	2012	Rutin, a flavonoid that is a main component of Saussurea involucrata, attenuates the senescence effect in D-galactose aging mouse model	Yang Y.-C.; Lin H.-Y.; KANG-YI SU ; Chen C.-H.; Yu Y.-L.; Lin C.-C.; SUNG-LIANG YU ; Yan H.-Y.; Su K.-J.; Chen Y.-L.S.	Evidence-based Complementary and Alternative Medicine	44	33
73	2012	Serine protease hepsin regulates hepatocyte size and hemodynamic retention of tumor cells by hepatocyte growth factor signaling in mice	Hsu Y.-C.; HSIANG-PO HUANG ; Yu I.-S.; KANG-YI SU ; Lin S.-R.; WEI-CHOU LIN ; Wu H.-L.; Shi G.-Y.; Tao M.-H.; Kao C.-H.; YAO-MING WU ; Martin P.E.; Lin S.-Y.; PAN-CHYR YANG ; SHU-WHA LIN	Hepatology	27	24
74	2012	Potential therapeutic role of Z-isochaihulactone in lung cancer through induction of apoptosis via notch signaling	Ou J.-P.; Lin H.-Y.; KANG-YI SU ; SUNG-LIANG YU ; Tseng I.-H.; Chen C.-J.; Hsu H.-C.; Chan D.-C.; Sophia Chen Y.-L.	Evidence-based Complementary and Alternative Medicine	15	13
75	2012	RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer	TZU-HSIU TSAI ; KANG-YI SU ; SHANG-GIN WU ; YIH-LEONG CHANG ; Luo S.-C.; Jane I.-S.; CHONG-JEN YU ; Yue S.-L.; JIN-YUAN SHIH ; PAN-CHYR YANG	European Respiratory Journal	42	37
76	2012	Pretreatment Epidermal Growth Factor Receptor (EGFR) T790M mutation predicts shorter EGFR tyrosine kinase inhibitor response duration in patients with non-small-cell lung cancer	KANG-YI SU ; Chen H.-Y.; Li K.-C.; Kuo M.-L.; CHIH-HSIN YANG ; Chan W.-K.; Ho B.-C.; Chang G.-C.; JIN-YUAN SHIH ; SUNG-LIANG YU ; PAN-CHYR YANG	Journal of Clinical Oncology	464	428
77	2011	Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor	Chang T.-H.; Tsai M.-F.; KANG-YI SU ; SHANG-GIN WU ; Huang C.-P.; SUNG-LIANG YU ; Yu Y.-L.; Lan C.-C.; CHIH-HSIN YANG ; Lin S.-B.; Wu C.-P.; JIN-YUAN SHIH ; PAN-CHYR YANG	American Journal of Respiratory and Critical Care Medicine	144	140
78	2011	Enterovirus-induced miR-141 contributes to shutoff of host protein translation by targeting the translation initiation factor eIF4E	Ho B.-C.; SUNG-LIANG YU ; Chen J.J.W.; SUI-YUAN CHANG ; BO-SHIUN YAN ; Hong Q.-S.; Singh S.; CHUAN-LIANG KAO ; Chen H.-Y.; KANG-YI SU ; Li K.-C.; Cheng C.-L.; Cheng H.-W.; Lee J.-Y.; Lee C.-N.; PAN-CHYR YANG	Cell Host and Microbe	135	127
79	2011	Clustered genomic alterations in chromosome 7p dictate outcomes and targeted treatment responses of lung adenocarcinoma with EGFR-activating mutations	Yuan S.; SUNG-LIANG YU ; Chen H.-Y.; Hsu Y.-C.; KANG-YI SU ; HUEI-WEN CHEN ; Chen C.-Y.; CHONG-JEN YU ; JIN-YUAN SHIH ; YIH-LEONG CHANG ; Cheng C.-L.; Hsu C.-P.; Hsia J.-Y.; Lin C.-Y.; Wu G.; Liu C.-H.; Wang C.-D.; Yang K.-C.; Chen Y.-W.; Lai Y.-L.; Hsu C.-C.; Lin T.-C.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Chen J.J.W.; Chang G.-C.; Li K.-C.; PAN-CHYR YANG	Journal of Clinical Oncology	28	26
80	2007	Mice deficient in collapsin response mediator protein-1 exhibit impaired long-term potentiation and impaired spatial learning and memory	KANG-YI SU ; Chien W.-L.; WEN-MEI FU ; Yu I.-S.; HSIANG-PO HUANG ; PEI-HSIN HUANG ; Lin S.-R.; JIN-YUAN SHIH ; Lin Y.-L.; Hsueh Y.-P.; PAN-CHYR YANG ; SHU-WHA LIN	Journal of Neuroscience	76	74
81	2006	Decreased expressions of hepsin in human hepatocellular carcinomas	CHIEN-HUNG CHEN ; KANG-YI SU ; Tao M.-H.; SHU-WHA LIN ; Su Y.-H.; Tsai Y.-C.; Cheng K.-C.; YUNG-MING JENG ; JIN-CHUAN SHEU	Liver International	17	18

研究成果

全部

期刊文章

其他

依作者

主題

依日期

依類型

全文

研究成果 (全部) 全部 期刊文章 其他 顯示/隱藏過濾條件

依作者

主題

依日期

依類型

全文

研究成果

全部

期刊文章

其他